FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products

    NEXT STORY
    Mateon Therapeutics Team Publishes Three New Peer-Reviewed Oncology Articles Outlining the Clinical Impact Potential of Its First-In-Class Anti-TGF-Beta RNA Therapeutic OT101/Trabedersen
    PREV STORY
    Fortress Biotech to Participate in December 2019 Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC

    author_avatar
    NASDAQ Market News

    Surgical Care Affiliates Partners With The Surgery Center at Doral

    author_avatar
    NASDAQ Market News

    NewLink Genetics to Host Its Second Quarter 2018 Financial Results Conference Call on July 31, 2018

    AMES, Iowa, July 10, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that ...

    author_avatar
    NASDAQ Market News